Enanta Pharmaceuticals Inc Stock Performance
as on April 2, 2026 at 4:06 am IST
Day's Low
Day's High
$12.14$13.32
8.17%
Downside
0.76%
Upside
52 Week's Low
52 Week's High
$4.09$17.1569.06%
Downside
29.73%
Upside
Enanta Pharmaceuticals Inc share price movements today
- Previous Close
- $12.63
- Open
- $12.14
- Volume
- 176.5K
- Day's Low - High
- $12.14 - $13.32
- 52 Week Low - High
- $4.09 - $17.15
Enanta Pharmaceuticals Inc Historical Returns
- 1 Month Return
- -11.68 %
- 3 Month Return
- -19.91 %
- 1 Year Return
- + 137.41 %
- 3 Year Return
- -68.77 %
- 5 Year Return
- -75.14 %
Enanta Pharmaceuticals Inc Stock Fundamentals & Key Indicators
Check Enanta Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$353.5M
EPS (TTM)
-2.125
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.66%
PE Ratio (TTM)
-2.39
Industry PE ratio
-1.86665
PEG Ratio
0EBITDA
-68.1M
Revenue (TTM)
67.0M
Profit Margin
-106.80%
Return On Equity TTM
-60.01%
Enanta Pharmaceuticals Inc Stock Valuation
Track how Enanta Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Enanta Pharmaceuticals Inc in the last 5 years
Lowest (-15.76x)
December 31, 2021
Today (-2.39x)
April 1, 2026
Industry (-1.87x)
April 1, 2026
Highest (-1.36x)
March 31, 2025
Today’s Price to Earnings Ratio: -2.39x
Enanta Pharmaceuticals Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Enanta Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $353.5M | -75.14% | -2.39 | -106.80% | |
| BUY | $35.2B | 361.4% | -16.34 | -210.54% | |
| BUY | $41.9B | 133.32% | 135.08 | 8.45% | |
| BUY | $112.6B | 109.6% | 28.91 | 32.94% | |
| BUY | $79.2B | 62.69% | 18.05 | 31.41% |
Stock Returns calculator for Enanta Pharmaceuticals Inc Stock including INR - Dollar returns
The Enanta Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Enanta Pharmaceuticals Inc investment value today
Current value as on today
₹2,70,898
Returns
₹1,70,898
(+170.9%)
Returns from Enanta Pharmaceuticals Inc Stock
₹1,48,496 (+148.5%)
Dollar Impact
₹22,402 (+22.4%)
Analyst Recommendation on Enanta Pharmaceuticals Inc Stock
Based on 14 analysts
64.29%
Buy
28.57%
Hold
7.14%
Sell
Based on 14 analysts, 64.29% of analysts recommend a 'BUY' rating for Enanta Pharmaceuticals Inc. Average target price of $18.5
Enanta Pharmaceuticals Inc Share Price Target
Get share price movements and forecasts by analysts on Enanta Pharmaceuticals Inc.
What analysts predicted
28.54%UPSIDE
Target Price
$18.5
Current Price
$13.22
Analyzed by
14 Analysts
Target
$18.50
Enanta Pharmaceuticals Inc target price $18.5, a slight upside of 28.54% compared to current price of $13.22. According to 14 analysts rating.
Enanta Pharmaceuticals Inc Stock’s Investor Sentiment and Interest
Search interest for Enanta Pharmaceuticals Inc Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Enanta Pharmaceuticals Inc Quarterly Profit & Loss
All numbers in Millions USD
Enanta Pharmaceuticals Inc Annual Profit & Loss
All numbers in Millions USD
Enanta Pharmaceuticals Inc Quarterly Cash Flow
All numbers in Millions USD
Enanta Pharmaceuticals Inc Annual Cash Flow
All numbers in Millions USD
Enanta Pharmaceuticals Inc News & Key Events
Today's Timeline - 29 November
Sun, 05:52 AM
-Enanta Pharmaceuticals' common stock and options are under a Lock-Up Agreement ending on November 30, 2025.
Insights on Enanta Pharmaceuticals Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 15.12M → 18.61M (in $), with an average increase of 18.8% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -18.7M → -11.93M (in $), with an average increase of 56.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 year, ENTA stock has moved up by 137.4%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ENTA has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 3 years, Insmed Incorporated has given 859.1% return, outperforming this stock by 927.9%
About Enanta Pharmaceuticals Inc
| Organisation | Enanta Pharmaceuticals Inc |
| Headquarters | 4 Kingsbury Avenue, Watertown, MA, United States, 02472 |
| Industry | Health Technology |
| CEO | Dr. Jay R. Luly Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Enanta Pharmaceuticals Inc
Name | Title |
|---|---|
Mr. Matthew P. Kowalsky J.D. | Chief Legal Officer & Corporate Secretary |
Dr. Jay R. Luly Ph.D. | President, CEO & Director |
Dr. Yat Sun Or Ph.D. | Chief Scientific Officer |
Dr. Scott T. Rottinghaus M.D. | Chief Medical Officer |
Ms. Kathleen S. Capps CPA | Executive Director of Accounting, Controller & Interim Principal Accounting Officer |
Mr. Brendan Luu | Chief Business Officer |
Mr. Harry R. Trout III | VP of Finance & Interim Principal Financial Officer |
Ms. Jennifer Viera | Executive Director of Investor Relations & Corporate Communications |
Mr. Nathaniel S. Gardiner J.D. | Consultant |
Ms. Tara Lynn Kieffer Ph.D. | Chief Product Strategy Officer |
FAQs
What is Enanta Pharmaceuticals Inc share price today?
Enanta Pharmaceuticals Inc share price today is $13.22 as on . Enanta Pharmaceuticals Inc share today touched a day high of $13.32 and a low of $12.14.
What is the 52 week high and 52 week low for Enanta Pharmaceuticals Inc share?
Enanta Pharmaceuticals Inc share touched a 52 week high of $17.15 on and a 52 week low of $4.09 on . Enanta Pharmaceuticals Inc stock price today i.e. is trending at $13.22,which is 22.92% down from its 52 week high and 223.23% up from its 52 week low.
What is Enanta Pharmaceuticals Inc's market capitalisation today?
Enanta Pharmaceuticals Inc market capitalisation is $0.00T as on .
How to invest in Enanta Pharmaceuticals Inc Stock (ENTA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Enanta Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Enanta Pharmaceuticals Inc Shares that will get you 0.1135 shares as per Enanta Pharmaceuticals Inc share price of $13.22 per share as on April 1, 2026 at 10:36 pm IST.
What is the minimum amount required to buy Enanta Pharmaceuticals Inc Stock (ENTA) from India?
Indian investors can start investing in Enanta Pharmaceuticals Inc (ENTA) shares with as little as ₹93.295 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹932.95 in Enanta Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Enanta Pharmaceuticals Inc share’s latest price of $13.22 as on April 1, 2026 at 10:36 pm IST, you will get 0.7564 shares of Enanta Pharmaceuticals Inc. Learn more about
fractional shares .
What are the returns that Enanta Pharmaceuticals Inc has given to Indian investors in the last 5 years?
Enanta Pharmaceuticals Inc stock has given -75.14% share price returns and 28.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?